{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:59:01Z","timestamp":1775581141812,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671965"],"award-info":[{"award-number":["81671965"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801948"],"award-info":[{"award-number":["81801948"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1601225"],"award-info":[{"award-number":["U1601225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["201607020016"],"award-info":[{"award-number":["201607020016"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2014A020212150"],"award-info":[{"award-number":["2014A020212150"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cca.2020.08.035","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T21:43:34Z","timestamp":1598478214000},"page":"647-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Admission IL-32 concentration predicts severity and mortality of severe community-acquired pneumonia independently of etiology"],"prefix":"10.1016","volume":"510","author":[{"given":"Jinhui","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinli","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingli","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.08.035_b0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","article-title":"Identification of a novel gene expressed in activated natural killer cells and T cells","volume":"148","author":"Dahl","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2020.08.035_b0010","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cca.2020.08.035_b0015","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.0813334106","article-title":"IL-32-dependent effects of IL-1beta on endothelial cell functions","volume":"106","author":"Nold-Petry","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cca.2020.08.035_b0020","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","article-title":"IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism","volume":"102","author":"Netea","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl 2","key":"10.1016\/j.cca.2020.08.035_b0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/cc4927","article-title":"Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database","volume":"10","author":"Woodhead","year":"2006","journal-title":"Crit. Care"},{"issue":"Suppl 6","key":"10.1016\/j.cca.2020.08.035_b0030","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/cc7025","article-title":"Demographics, guidelines, and clinical experience in severe community-acquired pneumonia","volume":"12","author":"Rello","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2020.08.035_b0035","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","article-title":"Community-acquired pneumonia","volume":"386","author":"Prina","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2020.08.035_b0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.08.035_b0045","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc13812","article-title":"Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort","volume":"18","author":"Walden","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2020.08.035_b0050","article-title":"Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection","volume":"3","author":"Li","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2020.08.035_b0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cyto.2019.01.012","article-title":"Increased expression of IL-32 correlates with IFN-gamma, Th1 and Tc1 in virologically suppressed HIV-1-infected patients","volume":"120","author":"Santinelli","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2020.08.035_b0060","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24285","article-title":"Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis","volume":"53","author":"Moschen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2020.08.035_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1\/IL-18\/interferon-gamma-dependent mechanism","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.cca.2020.08.035_b0070","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/IAI.00637-12","article-title":"Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation","volume":"80","author":"Sakitani","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cca.2020.08.035_b0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/path.2899","article-title":"IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis","volume":"224","author":"Jeong","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.cca.2020.08.035_b0080","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","article-title":"Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease","volume":"149","author":"Shioya","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2020.08.035_b0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.08.035_b0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"Suppl 2","key":"10.1016\/j.cca.2020.08.035_b0095","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cca.2020.08.035_b0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cyto.2009.03.007","article-title":"Molecular characterization of IL-32 in human endothelial cells","volume":"46","author":"Kobayashi","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2020.08.035_b0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1183\/09031936.06.00130305","article-title":"Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds","volume":"27","author":"Niederman","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cca.2020.08.035_b0110","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1378\/chest.06-1994","article-title":"Recent advances in community-acquired pneumonia: inpatient and outpatient","volume":"131","author":"Niederman","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cca.2020.08.035_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1469-0691.2002.00349.x","article-title":"Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia","volume":"8","author":"Brunkhorst","year":"2002","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cca.2020.08.035_b0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ageing\/afp164","article-title":"C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia","volume":"38","author":"Thiem","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.cca.2020.08.035_b0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1515\/cclm-2014-0456","article-title":"Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia","volume":"53","author":"Zhydkov","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2020.08.035_b0130","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/cc10258","article-title":"Association between IL-32 genotypes and outcome in infection-associated acute lung injury","volume":"15","author":"Arcaroli","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2020.08.035_b0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.08.035_b0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aeh163","article-title":"Physiology of the endothelium","volume":"93","author":"Galley","year":"2004","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.cca.2020.08.035_b0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","article-title":"The endothelium in sepsis","volume":"45","author":"Ince","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.cca.2020.08.035_b0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/JLB.4MIR1118-425R","article-title":"New strategies for treatment of infectious sepsis","volume":"106","author":"Ward","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2020.08.035_b0155","first-page":"123","article-title":"Host innate immune responses to microbial pathogens","volume":"11","author":"Delaloye","year":"2013","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.cca.2020.08.035_b0160","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1183\/09031936.00074410","article-title":"Systemic cytokine response in patients with community-acquired pneumonia","volume":"37","author":"Endeman","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cca.2020.08.035_b0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clinbiochem.2003.11.001","article-title":"Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia","volume":"37","author":"Igonin","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2020.08.035_b0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thx.2008.105312","article-title":"Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia","volume":"64","author":"Menendez","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.cca.2020.08.035_b0175","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/CCM.0b013e3182257445","article-title":"Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia","volume":"39","author":"Ramirez","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2020.08.035_b0180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcrc.2009.05.002","article-title":"Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia","volume":"25","author":"Lee","year":"2010","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.cca.2020.08.035_b0185","first-page":"813","article-title":"Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia","volume":"10","author":"Fernandez-Serrano","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.cca.2020.08.035_b0190","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","article-title":"Identification of the most active interleukin-32 isoform","volume":"126","author":"Choi","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.cca.2020.08.035_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009458","article-title":"Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model","volume":"5","author":"Kobayashi","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2020.08.035_b0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2567.2010.03377.x","article-title":"Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene","volume":"132","author":"Lee","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.cca.2020.08.035_b0205","doi-asserted-by":"crossref","first-page":"814","DOI":"10.5483\/BMBRep.2008.41.11.814","article-title":"Proteinase 3-processed form of the recombinant IL-32 separate domain","volume":"41","author":"Kim","year":"2008","journal-title":"BMB Rep."},{"key":"10.1016\/j.cca.2020.08.035_b0210","doi-asserted-by":"crossref","first-page":"17868","DOI":"10.1074\/jbc.M900368200","article-title":"Interleukin-32 expression in the pancreas","volume":"284","author":"Nishida","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2020.08.035_b0215","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1073\/pnas.0712391105","article-title":"Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function","volume":"105","author":"Marcondes","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cca.2020.08.035_b0220","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA118.006255","article-title":"The proinflammatory cytokine TNFalpha induces DNA demethylation-dependent and -independent activation of interleukin-32 expression","volume":"294","author":"Zhao","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2020.08.035_b0225","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/thx.2009.133280","article-title":"Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis","volume":"65","author":"Chalmers","year":"2010","journal-title":"Thorax"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120304289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120304289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:02:44Z","timestamp":1757862164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120304289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":45,"alternative-id":["S0009898120304289"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.08.035","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Admission IL-32 concentration predicts severity and mortality of severe community-acquired pneumonia independently of etiology","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}